Sagar Lonial

67.3k citations

691 papers · 18.9k indexed · 5 hit papers · h-index 70

Impact in

Hematology top 0.01%
- Multiple Myeloma Research and Treatments
Oncology top 0.1%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research

Papers in

Hematology 581
- Multiple Myeloma Research and Treatments 551
Oncology 314
- Peptidase Inhibition and Analysis 132
- Cancer Treatment and Pharmacology 108

Co-authors: Jonathan L. Kaufman Paul G. Richardson Ajay K. Nooka Lawrence Boise Sundar Jagannath Kenneth C. Anderson Fadlo R. Khuri Asher Chanan‐Khan
Journals: Blood (256 papers)Journal of Clinical Oncology (108 papers)Cancer (17 papers)Leukemia (13 papers)Blood Cancer Journal (13 papers)
Partner nations: United States Spain Canada

In The Last Decade

Sagar Lonial

666 papers receiving 18.5k citations

Hit Papers

5 papers align trajectories log scale

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel 2023 · 77 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Blood Cancer Journal
2016 Blood
2009 Science Signaling
2007 New England Journal of Medicine
2006 Journal of Clinical Oncology

Peers

Countries citing papers authored by Sagar Lonial

Since Specialization

Citations

This map shows the geographic impact of Sagar Lonial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sagar Lonial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sagar Lonial more than expected).

Fields of papers citing papers by Sagar Lonial

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sagar Lonial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sagar Lonial. The network helps show where Sagar Lonial may publish in the future.

Co-authors

The 25 scholars most cited alongside Sagar Lonial, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sagar Lonial Line = papers co-authored together Sagar Lonial links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract Clinical Lymphoma Myeloma & Leukemia ·Sara A. Scott, Danielle Roberts, Vikas A. Gupta, Nisha S. Joseph, Craig C. Hofmeister, Madhav V. Dhodapkar, Sagar Lonial, Ajay K. Nooka, Jonathan L. Kaufman	2025	0
2	Biological and Clinical Significance of Endogenous and Chimeric Antigen Receptor (CAR) T Cell Immune Profiling in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Blood ·Bruno Paiva, Irene Manrique, Ethan Thompson, Timothy Campbell, Camila Guerrero, Nathan Martin, Larry D. Anderson, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, Shari M. Kaiser	2024	1
3	Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity npj Vaccines ·Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M. Switchenko, Bushra Wali, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar, Mehul S. Suthar	2024	0
4	Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice CA A Cancer Journal for Clinicians ·Rujul H Parikh, Sagar Lonial	2023	65
5	Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel Blood Cancer Journal ·Noopur Raje, Kenneth C. Anderson, Hermann Einsele, Yvonne A. Efebera, Francesca Gay, Sarah P. Hammond, Alexander M. Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krina K. Patel, Karthik Ramasamy, María‐Victoria Mateos Hit paper breakdown →	2023	77
6	Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma Clinical Cancer Research ·Benjamin G. Barwick, Vikas A. Gupta, Shannon M. Matulis, Jonathan C. Patton, Doris R. Powell, Yanyan Gu, David L. Jaye, Karen N. Conneely, Yin C. Lin, Craig C. Hofmeister, Ajay K. Nooka, Jonathan J. Keats, Sagar Lonial, Paula M. Vertino, Lawrence Boise	2021	10
7	Interim Analyses of Overall Survival (OS) from the TOURMALINE MM3 & MM4 Studies of Ixazomib Maintenance Following Primary Therapy in Multiple Myeloma (MM) Blood ·Meletios Α. Dimopoulos, S. Vincent Rajkumar, Sagar Lonial, Wee Joo Chng, Shinsuke Iida, María‐Victoria Mateos, Gareth J. Morgan, Arun Kumar, Kaveri Suryanarayan, Alexander Vorog, Andrew Fergus, Richard Labotka	2021	2
8	Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia Blood Cancer Discovery ·Akhilesh Kaushal, Ajay K. Nooka, Allison R. Carr, Katherine E. Pendleton, Benjamin G. Barwick, Renee Julia Manalo, Samuel S. McCachren, Vikas A. Gupta, Nisha S. Joseph, Craig C. Hofmeister, Jonathan L. Kaufman, Leonard T. Heffner, Stephen M. Ansell, Lawrence Boise, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar	2021	14
9	Idecabtagene Vicleucel (ide-cel, bb2121) in Relapsed and Refractory Multiple Myeloma (RRMM): Analyses of High-Risk Subgroups in the KarMMa Study Transplantation and Cellular Therapy ·Noopur Raje, David S. Siegel, Sundar Jagannath, Sagar Lonial, Nikhil C. Munshi, Philippe Moreau, Hartmut Goldschmidt, Michèle Cavo, Anna Truppel-Hartmann, Everton Rowe, Liping Huang, Amit Agarwal, Julie Wang, Timothy Campbell, Jesús F. San Miguel, Donna Reece	2021	2
10	DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling Clinical Cancer Research ·Jie Li, Chaoyun Pan, Austin C. Boese, JiHoon Kang, Anna D. Umano, Kelly R. Magliocca, Wenqing Yang, Yu Zhang, Sagar Lonial, Lingtao Jin, Sumin Kang	2020	48
11	Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma Journal of Clinical Oncology ·Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar, Craig C. Hofmeister, Dhwani Almaula, Leonard T. Heffner, Vikas A. Gupta, Lawrence Boise, Sagar Lonial, Ajay K. Nooka	2020	132
12	Daratumumab With Cetrelimab, an Anti–PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma Clinical Lymphoma Myeloma & Leukemia ·Yaël C. Cohen, Albert Oriol, Ka Lung Wu, Noa Lavi, Philip Vlummens, Carolyn C. Jackson, Wendy Garvin, Robin Carson, Wendy Crist, Jiayu Fu, Huaibao Feng, Hong Xie, Jordan M. Schecter, Jesús F. San Miguel, Sagar Lonial	2020	12
13	Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma Clinical Cancer Research ·Jatin J. Shah, Andrzej Jakubowiak, Owen A. O’Connor, Robert Z. Orlowski, R. Donald Harvey, Mitchell R. Smith, Daniel Lebovic, Catherine Diefenbach, Kevin R. Kelly, Zhaowei Hua, Allison Berger, George Mulligan, Hélène M. Faessel, Stephen Tirrell, Bruce J. Dezube, Sagar Lonial	2015	162
14	A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease Clinical Cancer Research ·Razelle Kurzrock, Peter M. Voorhees, Corey Casper, Richard R. Furman, Luis Fayad, Sagar Lonial, Hossein Borghaei, Sundar Jagannath, Lubomir Sokol, Saad Z. Usmani, Helgi van de Velde, Xiang Qin, Thomas A. Puchalski, Brett M. Hall, Manjula Reddy, Ming Qi, Frits van Rhee	2013	166
15	Tyrosine Phosphorylation of Lactate Dehydrogenase A Is Important for NADH/NAD ⁺ Redox Homeostasis in Cancer Cells Molecular and Cellular Biology ·Jun Fan, Taro Hitosugi, Tae‐Wook Chung, Jianxin Xie, Qingyuan Ge, Ting‐Lei Gu, Roberto D. Polakiewicz, Georgia Z. Chen, Titus J. Boggon, Sagar Lonial, Fadlo R. Khuri, Sumin Kang, Jing Chen	2011	188
16	The NEDD8-Activating Enzyme Inhibitor, MLN4924, Cooperates with TRAIL to Augment Apoptosis through Facilitating c-FLIP Degradation in Head and Neck Cancer Cells Molecular Cancer Therapeutics ·Liqun Zhao, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi‐Yong Sun	2011	35
17	Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy Cancer Research ·Lei Fu, Young‐Ae Kim, Xuerong Wang, Xiaoyun Wu, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi‐Yong Sun	2009	129
18	Clinical uses of GM-CSF, a critical appraisal and update SHILAP Revista de lepidopterología ·Martha Arellano, Sagar Lonial	2008	5
19	The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells Cancer Research ·Liu X, Ping Yue, Shuzhen Chen, Liping Hu, Sagar Lonial, Fadlo R. Khuri, Shi‐Yong Sun	2007	141
20	The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway Molecular Cancer Therapeutics ·Heath A. Elrod, Yidan Lin, Ping Yue, Xuerong Wang, Sagar Lonial, Fadlo R. Khuri, Shi‐Yong Sun	2007	79

About Sagar Lonial

Sagar Lonial is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 691 papers that have together received 18.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (551 papers), Protein Degradation and Inhibitors (273 papers), Peptidase Inhibition and Analysis (132 papers), Cancer Treatment and Pharmacology (108 papers), Chronic Lymphocytic Leukemia Research (82 papers), Ubiquitin and proteasome pathways (76 papers), Histone Deacetylase Inhibitors Research (58 papers) and Monoclonal and Polyclonal Antibodies Research (42 papers). The work is most often cited by research in Hematology (11.9k citations), Oncology (8.8k citations), Genetics (2.0k citations), Molecular Biology (12.3k citations) and Immunology (2.0k citations). Sagar Lonial has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Jonathan L. Kaufman, Paul G. Richardson, Ajay K. Nooka, Lawrence Boise, Sundar Jagannath, Kenneth C. Anderson, Fadlo R. Khuri, Asher Chanan‐Khan, Edmund K. Waller and Edward A. Stadtmauer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Leukemia and Blood Cancer Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact